Lilly Confirms Date and Conference Call for Second-Quarter 2010 Financial Results Announcement

INDIANAPOLIS, July 9 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the second quarter of 2010 on Thursday, July 22, 2010.  Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance.

The conference call will be held from 9:00 a.m. to 10:00 a.m. EDT.  Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at www.lilly.com.  The webcast of the conference call will be available for replay through August 20, 2010.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. F-LLY

(Logo:  http://photos.prnewswire.com/prnh/20031219/LLYLOGO  )

(Logo:  http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

SOURCE Eli Lilly and Company

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.